- Home
- ITOS vs SBXD Comparison
ITOS vs SBXD Comparison
Compare ITOS & SBXD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- SBXD
- Stock Information
- Founded
- ITOS 2011
- SBXD 2024
- Country
- ITOS United States
- SBXD United States
- Employees
- ITOS N/A
- SBXD N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- SBXD
- Sector
- ITOS Health Care
- SBXD
- Exchange
- ITOS Nasdaq
- SBXD NYSE
- Market Cap
- ITOS 270.7M
- SBXD 257.1M
- IPO Year
- ITOS 2020
- SBXD 2024
- Fundamental
- Price
- ITOS $7.19
- SBXD $10.17
- Analyst Decision
- ITOS Strong Buy
- SBXD
- Analyst Count
- ITOS 3
- SBXD 0
- Target Price
- ITOS $26.00
- SBXD N/A
- AVG Volume (30 Days)
- ITOS 334.2K
- SBXD 33.3K
- Earning Date
- ITOS 03-05-2025
- SBXD 01-01-0001
- Dividend Yield
- ITOS N/A
- SBXD N/A
- EPS Growth
- ITOS N/A
- SBXD N/A
- EPS
- ITOS N/A
- SBXD N/A
- Revenue
- ITOS $35,000,000.00
- SBXD N/A
- Revenue This Year
- ITOS N/A
- SBXD N/A
- Revenue Next Year
- ITOS $121.70
- SBXD N/A
- P/E Ratio
- ITOS N/A
- SBXD N/A
- Revenue Growth
- ITOS 177.89
- SBXD N/A
- 52 Week Low
- ITOS $6.67
- SBXD $9.95
- 52 Week High
- ITOS $18.75
- SBXD $10.40
- Technical
- Relative Strength Index (RSI)
- ITOS 48.18
- SBXD N/A
- Support Level
- ITOS $6.73
- SBXD N/A
- Resistance Level
- ITOS $7.32
- SBXD N/A
- Average True Range (ATR)
- ITOS 0.38
- SBXD 0.00
- MACD
- ITOS 0.03
- SBXD 0.00
- Stochastic Oscillator
- ITOS 53.06
- SBXD 0.00
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About SBXD SILVERBOX CORP IV
SilverBox Corp IV is a blank check company.